TRIM21 acts as a tumor suppressor by promoting ferroptosis in pancreatic cancer, suggesting that targeting the TRIM21-METTL3-SLC7A11 axis may be a novel effective therapeutic strategy for pancreatic cancer. This evidence concerns the gene METTL3 and neoplasm.